Title: A Rare Genetic Disorder Dyskeratosis Congenita with Vivid Manifestations

Authors: Dr Ghanshyam Verma, Dr Santwana Verma, Dr Nidhi Jindal, Dr GR Tegta, Dr Ajeet Negi

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i5.195

Abstract

Dyskeratosis congenita (DC) is a rare disease with an estimated annual incidence of, <1 in 1 million, with multiple and variable clinical manifestations. It is also known as Zinsser-Engman-Cole syndrome, have progressive bone marrow failure syndrome characterized by the triad of reticulated skin hyperpigmentation, nail dystrophy, and oral leukoplakia. Telomerase dysfunction, ribosome deficiency, and protein synthesis dysfunction evidence exists in this disorder. Early mortality is often associated with bone marrow failure, infections, fatal pulmonary complications, or malignancy. We report two cases of DC one with left hip avascular necrosis and other with fatal pulmonary complications, multidrug resistant pulmonary tuberculosis. First patient had onset of symptoms at 10 years of age with lacy reticulated pigmentation over face, neck, upper chest, forearms and hands, nail dystrophy, intraoral lichenoid pigmentation and rough, sparse greyish hair and painful left hip joint. Episodes of severe anaemia managed with blood transfusions. No features suggestive of GIT, pulmonary and neurological involvement and no evidence of any malignancy were seen in first case. Avascular necrosis of hip joint is a still rare association with DC. He was managed with supportive treatment and left hip replacement surgery. Second case had skin and mucosal manifestations with total teeth loss by the age of 26 years, sensory neural deafness in left ear, drug resistance pulmonary tubercular infection as bone marrow failure resulted in immunosuppressive state in this case. Ultimately the patient scum to pulmonary manifestations of DC in the form of opportunistic infection.

Keywords: avascular hip necrosis, dyskeratosis congenital, reticular pigmentation, bone morrow failure, drug resistant pulmonary tuberculosis.

References

1.      Tanaka A, Kumagai S, Nakagawa K, Yamamoto E. Cole-Engman syndrome associated with leukoplakia of the tongue: a case report. J Oral Maxillofac Surg 1999; 57:1138-41.

2.      Drachtman RA, Alter BP. Dyskeratosis congenita: clinical and genetic heterogeneity. Report of a new case and review of the literature. Am J Pediatr Hematol Oncol 1992; 14(4):297–304.

3.      Walne AJ, Dokal I. Dyskeratosis congenita: a historical perspective. Mech Ageing Dev 2008; 129(1–2):48–59.

4.      Dokal I. Dyskeratosis congenita in all its forms. Br J Haematol 2000; 110(4): 768–79.

5.      Melvin H. Freedman. Kliegman: Nelson Textbook of Pediatrics, 18th ed. The Pancytopenias ch 468.

6.      Wiedemann HP, McGuire J, Dwyer JM, et al. Progressive immune failure in dyskeratosis congenita. Report of an adult in whom pneumocystis carnii and fatal disseminated candidiasis developed. Arch Intern Med 1984; 144: 397

7.      Imokawa S, Sato A, Toyoshima M, Yoshitomi A, Tamura R, Suda T, Suganuma H, Yagi T, Iwata M, Hayakawa H, et al. Dyskeratosis congenita showing usual interstitial pneumonia. Intern Med.1994; 33(4):226-30

8.      Fernández García MS, Teruya-Feldstein J. The diagnosis and treatment of dyskeratosis congenita: a review. J Blood Med. 2014; 5:157-67.

9.      Erduran E, Hacisalihoglu S, Ozoran Y. Treatment of dyskeratosis congenita with granulocyte-macrophage colony-stimulating factor and erythropoietin. J Pediatr Hematol Oncol. Apr 2003; 25(4):333-5.

10.  Tomita K, Ishii M. A case of Cole- Engman syndrome: Effect of etretinate on the oral leukoplakia. Acta Dermatol Kyoto 1992; 87:567.

Corresponding Author

Dr Ghanshyam Verma

Dept. of Dermatology, Venereology and Leprosy, Indira Gandhi Medical College, Shimla, HP

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.